24 April 2023 | Monday | News
Image Source| Public Domain
CVL is the most comprehensive cardiovascular platform in the country. By partnering with CVL, FCCI will join a network of leading practices across the country and enhance its access to robust cardiovascular solutions. CVL has built a proven model that leverages five strategic pillars: service, people, quality, growth, and finance to fulfill its mission.
“This partnership was an obvious choice for FCCI because we are aligned with CVL in our mission to provide our patients with the highest quality cardiovascular available. We have known our colleagues at CVL for a long time, and have always felt it was a matter of when, not if, we would more formally collaborate,” said Yazan Khatib, MD, President of FCCI. “Our patients will continue to be the center of our universe, and our clinics will continue to operate in the same way, with the same team and with the high quality of care and innovation that our communities have come to expect from us.”
“We are excited to welcome FCCI to our cardiovascular platform,” said David Konur, CEO of CVL. “With continued partnerships like these, we will fundamentally change how cardiovascular care is delivered in the United States.”
© 2024 Biopharma Boardroom. All Rights Reserved.